• Explore /
  • Poster
  • / Trial in progress: A phase 2, multicenter, open-label study of DKN-01 in combination with tislelizumab and chemotherapy as 1L therapy in patients with unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ; DisTinGuish).

Trial in progress: A phase 2, multicenter, open-label study of DKN-01 in combination with tislelizumab and chemotherapy as 1L therapy in patients with unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ; DisTinGuish).

Abstract Poster

Authors

null

Keun-Wook Lee

Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South);

Keun-Wook Lee , Markus H. Moehler , David Cunningham , Zev A. Wainberg , Hope Elizabeth Uronis , Do-Youn Oh , In-Ho Kim , Byoung Yong Shim , Sun Jin Sym , Rachel A Altura , Melissa C Stilian , Elizabeth C Parker , Samuel J Klempner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04363801

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS484)

DOI

10.1200/JCO.2023.41.4_suppl.TPS484

Abstract #

TPS484

Poster Bd #

N19

Abstract Disclosures

Similar Posters

First Author: Samuel J Klempner

First Author: Samuel J Klempner

First Author: Kohei Shitara

First Author: Sylvie Lorenzen